Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

EPOR Antikörper

EPOR Reaktivität: Human FACS, cELISA Wirt: Maus Monoclonal VP-2E8 unconjugated
Produktnummer ABIN1720915
  • Target Alle EPOR Antikörper anzeigen
    EPOR (Erythropoietin Receptor (EPOR))
    Reaktivität
    • 121
    • 57
    • 46
    • 9
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    Human
    Wirt
    • 106
    • 16
    • 6
    • 1
    Maus
    Klonalität
    • 115
    • 14
    Monoklonal
    Konjugat
    • 65
    • 13
    • 7
    • 5
    • 5
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser EPOR Antikörper ist unkonjugiert
    Applikation
    • 91
    • 44
    • 25
    • 21
    • 19
    • 15
    • 14
    • 14
    • 11
    • 5
    • 5
    • 5
    • 4
    • 2
    • 2
    • 1
    Flow Cytometry (FACS), Cell-ELISA (cELISA)
    Spezifität
    Anti-human Epo-R
    Produktmerkmale
    Selection: Based on recognition of the complete native protein expressed on transfected mammalian cells
    Aufreinigung
    Protein G
    Immunogen
    genetic immunisation with cDNA encoding the ECD of human Epo-R
    Klon
    VP-2E8
    Isotyp
    IgG1
    Top Product
    Discover our top product EPOR Primärantikörper
  • Applikationshinweise
    Flow cytometry: 1.2 µg/10^6 cells
    ELISA: 1:200 - 1:400
    CELISA: 1:200 - 1:400
    For each application a titration should be performed to determine the optimal concentration.
    Kommentare

    Synonyms: Erythropoietin receptor

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Buffer
    PBS, pH 7.2
    Handhabung
    Avoid repeated freezing and thawing.
    Lagerung
    4 °C
    Informationen zur Lagerung
    short term: 2 °C - 8 °C, long term: -20 °C
  • Maxwell, Melendez-Rodríguez, Matchett, Aragones, Ben-Califa, Jaekel, Hengst, Lindner, Bernardini, Brockmeier, Fandrey, Grunert, Oster, Mittelman, El-Tanani, Thiersch, Schneider Gasser, Gassmann et al.: "Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementation. ..." in: British journal of haematology, Vol. 168, Issue 3, pp. 429-42, (2015) (PubMed).

    Hedley, Allan, Xenocostas: "The role of erythropoietin and erythropoiesis-stimulating agents in tumor progression." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 17, Issue 20, pp. 6373-80, (2011) (PubMed).

  • Target
    EPOR (Erythropoietin Receptor (EPOR))
    Andere Bezeichnung
    EPOR (EPOR Produkte)
    Synonyme
    EPOR antikoerper, epor antikoerper, EPO-R antikoerper, erythropoietin receptor antikoerper, erythropoietin receptor L homeolog antikoerper, EPOR antikoerper, epor antikoerper, Epor antikoerper, epor.L antikoerper
    Hintergrund
    Erythropoietin receptor (Epo-R) belongs to the cytokine receptor family and is a 507 amino acid type I transmembrane protein. EpoR pre-exists as dimers which changes the homodimerized state after binding of its 34 kDa ligand erythropoietin (Epo). Erythropoietin is the primary regulator of erythropoiesis, and promotes the survival, proliferation, and differentiation of erythroid progenitor cells. Both, Epo and Epo-R are essential for the production of red blood cells due to Epo exerts its function through the Epo receptor. The Epo-R is also expressed in many organs outside the bone marrow, suggesting that Epo is a pleiotropic anti-apoptotic factor. Signaling pathways have been shown to influence numerous cellular functions in normal and tumor cells, including proliferation, apoptosis, and drug resistance.
    UniProt
    P19235
    Pathways
    JAK-STAT Signalweg
Sie sind hier:
Kundenservice